Search
Tyra Biosciences Inc
TYRAAdd to Watchlist
31.880USD
-1.180-3.57%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.90BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
RA Capital Management, LP
20.51%
Nextech Invest, Ltd.
6.82%
Alta Partners
6.43%
Commodore Capital LP
5.67%
Farallon Capital Management, L.L.C.
5.02%
Other
55.56%
Shareholders
Shareholders
Proportion
RA Capital Management, LP
20.51%
Nextech Invest, Ltd.
6.82%
Alta Partners
6.43%
Commodore Capital LP
5.67%
Farallon Capital Management, L.L.C.
5.02%
Other
55.56%
Shareholder Types
Shareholders
Proportion
Venture Capital
30.33%
Hedge Fund
23.60%
Investment Advisor
23.33%
Investment Advisor/Hedge Fund
16.48%
Individual Investor
2.68%
Research Firm
0.83%
Pension Fund
0.27%
Bank and Trust
0.15%
Corporation
0.07%
Other
2.25%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
285
58.08M
97.63%
-7.29M
2025Q4
254
55.68M
104.33%
-9.18M
2025Q3
246
56.81M
106.44%
-5.53M
2025Q2
237
58.64M
110.28%
+1.26M
2025Q1
239
56.06M
105.46%
-647.87K
2024Q4
219
50.96M
100.70%
-3.70M
2024Q3
195
53.66M
101.74%
-3.04M
2024Q2
179
53.85M
102.74%
-1.82M
2024Q1
167
53.85M
102.76%
+5.34M
2023Q4
151
42.86M
99.62%
-3.01M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
RA Capital Management, LP
12.20M
22.65%
--
--
Dec 31, 2025
Nextech Invest, Ltd.
4.06M
7.53%
--
--
Dec 31, 2025
Alta Partners
3.82M
7.1%
-256.87K
-6.30%
Dec 31, 2025
Commodore Capital LP
3.38M
6.27%
--
--
Dec 31, 2025
Farallon Capital Management, L.L.C.
2.98M
5.54%
+918.00K
+44.42%
Feb 12, 2026
Janus Henderson Investors
2.94M
5.45%
+60.64K
+2.11%
Dec 31, 2025
TCG Crossover Management, LLC
2.90M
5.38%
--
--
Dec 31, 2025
Vestal Point Capital, LP
2.42M
4.5%
--
--
Dec 31, 2025
BVF Partners L.P.
2.13M
3.95%
-1.52M
-41.70%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
1.85M
3.43%
+185.43K
+11.15%
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
1.04%
ALPS Medical Breakthroughs ETF
0.34%
ProShares Ultra Nasdaq Biotechnology
0.08%
Invesco Nasdaq Biotechnology ETF
0.08%
iShares Micro-Cap ETF
0.07%
iShares Biotechnology ETF
0.05%
Avantis US Small Cap Equity ETF
0.03%
iShares Russell 2000 Value ETF
0.02%
Schwab U.S. Small-Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion1.04%
ALPS Medical Breakthroughs ETF
Proportion0.34%
ProShares Ultra Nasdaq Biotechnology
Proportion0.08%
Invesco Nasdaq Biotechnology ETF
Proportion0.08%
iShares Micro-Cap ETF
Proportion0.07%
iShares Biotechnology ETF
Proportion0.05%
Avantis US Small Cap Equity ETF
Proportion0.03%
iShares Russell 2000 Value ETF
Proportion0.02%
Schwab U.S. Small-Cap ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%